Supplementary Information

Supplementary Information Glossary 175

Industrial | Product-specific Terms

Bags, single-use Plastic disposable bag used in bioreactors and for storing liquids,

such as culture media, intermediate products and

biopharmaceuticals

Bioreactor In English-speaking countries, a bioreactor is a vessel used for

cultivating animal or human cells in a culture medium. In non-

English-speaking countries, the term bioreactor is also used

synonymously with the term fermenter to denote a system

used to multiply microorganisms. In either case, the vessel is

used to obtain cells, parts of these or one of their metabolites.

Disposable Used synonymously with “single-use"

Downstream processing Collective term for the various steps that follow fermentation

or cell cultivation (upstream processing) in the production of

biopharmaceuticals; for example, separation, purification and

concentration

FDA - Food and Drug Administration U.S. regulatory agency responsible for ensuring the safety and

efficacy of human and veterinary pharmaceuticals, biological

products, medical devices and foods

Fermentation Technical process used to produce or transform intra- or

extra-cellular substances with the help of microorganisms

Fluid management technologies Technologies and systems for the transportation and storage

of biological liquids

Membrane chromatography Selective separation of mixtures of substances by adsorption

to specifically modified membranes (membrane adsorbers) in

a flowing system

Membrane (filter) Thin film or foil made of polymers; because of the porous

structure, this film is suitable for filtration applications.

Monoclonal antibodies Synthetic antibodies used, in particular, in the treatment of

cancer, HIV and autoimmune diseases

PAT - Process Analytical Technology A strategy for the design, analysis and control of manufacturing

processes according to which quality characteristics of

intermediate or finished products are defined and then analyzed

and monitored using the critical process parameters identified

Purification An important step in downstream processing

Scale-up Transfer of scale or increase in size. Used to denote the

progression of a process that increases in a range from lab scale

to pilot scale to process scale, while retaining the same

technology, materials of construction and geometries

throughout

Single-use | Reusable product Disposable product, i.e., for one-time usage. A reusable product

is designed for repeated use.

Upstream processing In the manufacture of biopharmaceuticals, designates the

various steps that take place for seeding and propagating cells

that produce an active pharmaceutical ingredient

Validation Documented verification that systems, devices and processes

reproducibly deliver the desired result

Glossary

176 Supplementary Information Glossary

Business | Economic Terms

Amortization Amortization relates exclusively to potential reductions in the

value of goodwill and the allocation of the purchase price to

intangible assets acquired as carried out according to IFRS 3

Cash flow The amount of cash earned after paying all expenses and taxes;

i.e., the cash balance of inflows and outflows of funds

Compliance Observance of applicable laws, codes and other relevant rules

and regulations

Constant currencies; currency-adjusted In the presentation of figures, identical exchange rates are used

for each of the comparative periods.

DAX®, TecDAX® German stock indexes of the transaction service provider and

marketplace organizer Deutsche Börse AG

D&O insurance Directors’ and Officers’ liability insurance that covers

Supervisory and Executive Board members and managerial

employees

DVFA | SG The Methods Commission of the Society of Investment

Professionals in Germany (DFVA e.V.) and the Schmalenbach-

Gesellschaft (SG)

EBITDA Earnings before interest, taxes, depreciation and amortization;

in this context, amortization refers exclusively to the purchase

price allocation (PPA) to intangible assets acquired according to

IFRS 3.

EBITDA margin The ratio of EBITDA (earnings before interest, taxes, depreciation

and amortization) to sales

Equity ratio The ratio of equity to the balance sheet total

ERP Stands for “Enterprise Resource Planning”;

IT-based system for resource planning

Extraordinary items Exceptional or one-time expenses and income, such as

acquisition costs, restructuring costs and other non-operating

expenses

Fixed assets The sum of intangible assets, property, plant and equipment and

financial assets

Goodwill The difference between the price paid for a company or business

and its net assets; a form of intangible asset

Holding company A parent company that exists for the purpose of owning a

controlling interest or shares in several legally independent

subsidiaries that are subordinate within the organizational

hierarchy; this holding company conducts its business

exclusively through these subsidiaries.

Market capitalization The total number of shares outstanding of both classes issued by

the company, multiplied by the corresponding share price

Normalized financial result Financial result excluding fair value adjustments of hedging

instruments, as well as excluding non-periodic expenses and

income.

Normalized income tax Underlying income tax, based on underlying profit before tax

and on non-cash amortization.

Prime Standard Market segment of the Frankfurt Stock Exchange with high,

internationally accepted transparency requirements to meet the

needs of companies seeking to attract international investors.

Supply chain management Setup and coordination of integrated flows of materials,

information and finances (supply chains) over the entire value-

added process

Treasury Short- and medium-term liquidity management

Underlying Adjusted to eliminate extraordinary items (see definition

extraordinary item)

Supplementary Information Glossary 177

Other Terms

CRM Abbreviation for “Customer Relationship Management”;

practices, strategies and technologies that companies use to

manage and analyze customer interactions and data to improve

customer retention and drive sales growth

EHS Abbreviation for "Environment, Health and Safety”

EMEA The region comprising Europe, the Middle East and Africa; one

of the three reporting regions in the geographical allocation of

the Sartorius Group besides the Americas and Asia / Pacific

ERP Stands for "Enterprise Resource Planning";

IT-based resource planning system

ESG Abbreviation for “Environment, Social and Governance”; refers

to the three major factors of sustainable corporate management.

GEC Stands for the "Group Executive Committee"; the central

management body of the Sartorius Group. It currently is

comprised of six members: the three Executive Board members

of Sartorius AG and further executives with global responsibility

GHG Abbreviation for “Greenhouse Gas Protocol,” the international

standard for measuring and managing greenhouse gas emissions,

including reporting. The WHO stands for the “World Heath

Organization,” the coordination authority of the United Nations

for international public health

178 Supplementary Information Index

A Acquisitions | 9 | 25 ff. | 34 | 39 | 45 | 49 f. | 57 f. | 65 | 89 f.

| 111 | 116 f. | 132 ff. | 137 | 140 |

Annual financial statements | 13 f. | 53 ff. | 55 f. | 74 f. | 79

| 102 | 116 | 160 | 167

Annual Shareholders’ Meeting | 8 | 12 ff. | 19 | 70 ff. | 139

| 161 | 167 | 183

Appropriation of profits | 54 | 72 | 176

Auditor(s) | 13 | 14 | 55 | 67 | 70 | 74 | 160 | 163 ff.

B

Balance sheet | 9 | 12 | 14 | 37 | 39 ff. | 41 | 51 ff. | 60 f. | 65

| 67 f. | 110 | 112 | 114 ff. | 121 | 124 | 126

| 128 | 132 ff. | 138

Bioprocess Solutions | 8 f. | 22 | 24 f. | 27 | 29 | 32 ff. | 38

|42 ff. | 50 | 54 | 56 | 65 | 114 | 119 f.

|127 | 132 | 134 | 160 | 164

C

Capital expenditures | 23 | 37 | 39 | 41 | 50 | 57 | 59 | 62 f.

| 114 | 120 | 133 | 135 | 147

Cash flow(s) | 23 | 39 | 41 | 60 | 109 | 111 f. | 117 f. | 132 | 134

|138 | 140 | 145 | 154 ff. | 175

Compliance | 12 f. | 55 | 60 f. | 67 f. | 72 ff. | 86 | 89 | 95 f.

|102 f. | 168 | 175

Consolidated financial statements | 12 | 13 | 14 | 22 | 51 | 55

| 67 f. | 74 | 101 | 115 ff.

| 135 | 140 | 148 | 160 ff.

| 165 ff

Corporate governance | 12 f. | 70 ff. | 81 | 95 | 101 | 103 | 160

|171

Currency | 23 | 27 | 29 f. | 48 | 55 | 60 | 62 | 65 | 67 | 109 | 111 f.

|115 ff. | 121 | 129 f. | 132 f. | 135 | 137 ff. | 148 f.

|152 ff. | 158 f.

D

Depreciation | 35 | 52 | 65 | 111 |119 f. | 129 f. |132 ff. | 138 |

Dividend(s) | 8 | 14 | 19 f. | 39 | 51 | 53 | 69 | 75 | 111 ff. | 130

| 139 | 161 | 183

E

Earnings | 19 f. | 23 | 35 f. | 52 | 75 | 77 | 80 ff. | 108 f. |112

| 140

Earnings per share | 36 | 108 | 131

Earnings reserves | 52 | 112 | 126 | 145 | 147

EBIT | 34 ff. | 108 | 111 | 120

EBITDA | 9 | 23 | 27 | 35 | 39 ff. | 43 | 48 | 50 | 60 | 65 | 75 | 116

|119 f. | 156 | 175

Employees | 9 | 14 | 23 | 38 | 44 | 53 | 59 | 61 | 68 | 74 | 85 f.

| 91 ff. | 99 ff. |100 | 101 | 105 | 140 f. | 144

Employee benefits expense | 52 | 78 | 129 | 139 | 159

Equity | 23 | 40 | 51 f. | 110 | 112 f. | 115 f. | 126 | 137 |140

|145 f. | 149 | 151 f. | 154 | 163 | 175

Executive Board | 8 ff. | 12 ff. | 19 f. | 22 f. | 53 ff. | 68 - 78

| 80 | 84 ff. | 92 | 101 f. | 114 | 119 | 121

| 139 f. | 159 ff. | 164 | 168 ff. | 176

F

Financial instruments | 60 | 74 | 114 | 116 | 130 | 138 | 145 ff.

|159

Financing | 13 | 23 | 39 ff. | 50 | 60 | 110 | 115 | 117 | 121 |136

| 148 | 154 f.

Financial result | 20 | 35 f. | 108 | 111 | 117 | 119 f. | 130 | 154

|175

Fixed assets | 51 f. | 111 | 116 | 121 | 129 | 135 f. | 138 |175

Forecast report | 53 | 62 ff.

Foreign exchange, foreign exchange rates | 41 | 60 | 147 | 151

| 153 f.

G Group companies | 54 f. | 60 | 67 f. | 120 | 141

Group Executive Committee | 10 f. | 19 | 54 | 73 | 92 | 97 | 187

Group financial statements | 12 | 13 | 14 | 22 | 51 | 55 | 67 f.

| 74 | 101 | 115 ff. | 135 | 140 | 148

| 160 ff. | 165 ff

Group structure | 22 f. | 85 | 101

Group management report | 14 | 21 - 106 | 51 | 67 | 74 | 85

| 104 | 159 | 161 ff. | 165 ff.

I Intangible assets | 75 | 110 f. | 118 | 125 | 130 |132 ff. | 137

| 175

Interest income | 142 | 152

Inventories | 39 | 110 f. | 125 ff. | 137 f. f.

Investments | 23 | 37 | 39 | 41 | 50 | 57 | 59 | 62 f. | 114 | 120

|133 | 135 | 147

Investor relations | 18 | 86 | 168

Index

Supplementary Information Index 179

L

Lab Products & Services | 8 | 14 | 24 | 26 | 29 | 32 ff. | 38 | 47 ff.

|54 | 65 | 119 f. | 132 | 160 | 164

Liabilities | 35 | 39 ff. | 52 | 60 | 110 f. | 116 ff. | 121 | 125 ff.

| 130 | 137 | 144 | 146 | 1148 ff. | 154 ff.

M

Marketing | 22 | 27 | 34 | 38 | 44 | 54 | 86 | 91 | 129 | 168

N

Net debt | 23 | 39 ff. | 50 | 60 | 156

Net profit | 19 f. | 23 | 35 f. | 52 | 75 | 77 | 80 ff. | 108 f.

|112 | 140.

Note loans | 39 ff. | 69 | 148 | 151 | 156

O

Ordinary shares | 8 | 14 | 16 | 18 ff. | 36 | 53 | 69 | 74 | 108 | 113

| 131 | 138 f. | 159 | 161

P

Pension commitments | 80 | 84 | 118 | 140 f. | 161

Phantom stock, phantom stock units | 75 ff. | 81 f. | 159

Preference share(s) | 8 | 14 | 16 | 18 ff. | 36 | 53 | 69 | 74 | 108

| 113 | 131 | 138 f. | 159 | 161

Procurement | 54 | 56 | 60 f. | 147

Production | 8 | 12 | 22 | 24 f. | 27 | 30 ff. | 37 ff. | 41 | 44 | 46

|49 f. | 55 ff. | 60 f. | 63 f. | 85 f. | 88 - 93 | 97 ff.

|129 | 147 f. | 152 | 174

Products | 8 f. | 22 | 24 ff. | 30 f. | 37 | 44 ff. | 49 | 54 | 57 f. | 60

|64 f. | 71 | 86 | 89 | 91 | 97 f. | 100 ff. | 119| 127 f.

| 132 | 134 | 174

Profit | 12 f. | 18 | 23 | 34 ff. | 37 | 40 | 43 |48 | 50 ff. | 55 f.

| 59 ff. | 65 | 68 | 71 | 76 | 78 | 86 | 89 | 91 | 105 | 108 f.

| 111 f. | 116 ff. | 126 | 130 f. | 137 ff. | 147 | 149 | 152

| 154 f. | 159 | 163 f. | 175

Property, plant and equipment | 39 | 52 | 110 f. | 117 | 119 f.

| 125 | 135 ff.

Provisions | 52 | 110 f. | 118 | 137 | 140 | 143 f.

R

Ratio of Net Debt to Underlying EBITDA | 40

Regions | 8 | 12 | 33f. | 43 | 48 ff. | 62 | 65 | 91 | 96 | 120 | 127

|157 | 176

Remuneration of the Executive Board | 12

Research and Development | 28 | 34 | 37 f. | 53 | 89 f. | 129

Reserves | 52 | 110 f. | 118 | 137 | 140 | 143 f.

Restructuring | 119 | 143 | 175

Results | 12 f. | 18 | 23 | 34 ff. | 37 | 40 | 43 | 48 | 50 ff. | 55 f.

| 59 ff. | 65 | 68 | 71 | 76 | 78 | 86 | 89 | 91 | 105 | 108 f.

| 111 f. | 116 ff. | 126 | 130 f. | 137 ff. | 147 | 149 | 152

| 154 f. | 159 | 163 f. | 175

Retained profit | 52 | 112 | 126 | 145 | 147

Risk management system | 53 ff. | 68

Risk and opportunities report | 53 - 61 | 73 | 101 f.

S

Sales (and distribution) | 8 | 22 | 25 | 27 | 34 f. | 38 | 44 | 49 | 56 f.

| 65 | 86 | 91 | 97 | 108 | 119 | 125 | 127

| 129 | 135 | 138 | 168

Sales revenue | 8 f. | 12 | 16 | 23 | 25 | 27 | 29 | 30 f. | 33 ff.

| 37 | 39 | 43 | 48 | 50 ff. | 58 | 60 | 63 ff. | 75

| 91 | 97 f. | 108 |114 | 118 | 120 | 124 | 126 ff.

| 140 | 148 f. | 152 | 154 | 164 | 175

Sartorius Stedim Biotech | 22 | 35 | 51 | 83 ff. | 90 | 122 | 134

|139 | 168 | 170 f.

Segment reports | 119 f.

Shareholder structure | 19

Share(s) | 9 | 14 | 16 ff. | 22 f. | 35 f. | 53 | 65 | 69 f. | 74 ff.

| 78 f. | 104 f. | 108 | 112 ff. | 121 | 131 | 138 f.| 159

| 161 ff. | 167 | 175

Statement of profit or loss | 35 | 52 | 108 f. | 116 f. | 126 ff.

| 134 f. | 136 | 138 | 140 f. | 153

| 158 | 163

Stedim transaction | 134

Supervisory Board | 8 | 12 ff. | 19 f. | 22 | 53 ff. | 67 ff. | 83 f.

| 104 f. | 114 | 159 ff. | 164 f. | 167 ff.

Supply chain management | 46 | 49 | 56 | 175

Sustainability | 61 | 85 ff. | 101 | 105

T

Taxes | 35 f. | 52 | 95 | 108 ff. | 118 ff. | 125 | 130 | 132 | 137 ff.

| 144 | 154 f. | 175

Treasury | 41 | 152 | 157 | 175

W

Working capital | 23 | 39 ff. | 57 | 148

190 Supplementary Information A Local Presence Worldwide

SalesProduction | Production and Sales

The Americas

Oakville, ON, CanadaBohemia, NY, USABoston, MA, USAAnn Arbor, MI, USAArvada, CO, USANew Oxford, PA, USAAlbuquerque, NM, USAMexico City, MexicoYauco, Puerto RicoSão Paulo, BrazilBuenos Aires, ArgentinaLima, Peru

A Local Presence Worldwide

191Supplementary Information A Local Presence Worldwide

Europe | Africa

Dublin, IrelandRoyston, UKStonehouse, UKEpsom, UKGlasgow, UKBrussels, BelgiumDourdan, FranceAubagne, FranceLourdes, France Florence, ItalyMilan, ItalyMadrid, SpainBarcelona, Spain

Kajaani, FinlandHelsinki, FinlandMalmo, SwedenUmeå, SwedenSt. Petersburg, RussiaGoettingen, GermanyGuxhagen, GermanyLaupheim, GermanyPoznan, PolandBudapest, HungaryVienna, AustriaTagelswangen, SwitzerlandMohamdia, TunisiaBeit Haemek, Israel

Asia | Pacific

Beijing, ChinaShanghai, ChinaHong Kong, ChinaSeoul, South KoreaTokyo, JapanHanoi, VietnamBangkok, ThailandBangalore, IndiaKuala Lumpur, MalaysiaSingapore, SingaporeMelbourne, Australia

182 Supplementary Information A Local Presence Worlwide

Supplementary Information Financial Schedule 183

Financial Schedule

Annual Shareholders’ Meeting in Goettingen, Germany March 26, 2020

Payment of dividends1) March 31, 2020

Publication of first-quarter figures for 2020 April 21, 2020

Publication of first-half figures for 2020 July 21, 2020

Publication of nine-month figures for 2020 October 20, 2020

Publication of preliminary figures for fiscal 2020 January 2021

Annual press conference in Goettingen, Germany February 2021

Annual Shareholders’ Meeting in Goettingen, Germany March, 2021

Publication of first-quarter figures for 2020 April 2021

1) Subject to approval by the Annual Shareholders‘ Meeting

Contacts

Petra Kirchhoff Head of Corporate Communications & IR

Phone: 0551.308.1686 petra.kirchhoff@sartorius.com

Ben Orzelek Head of Investor Relations Phone: 0551.308.1668 ben.orzelek@sartorius.com

Katharina Tillmanns-Pelzer Manager Corporate Responsibility Phone: 0551.308.2893 katharina.tillmanns@sartorius.com

This is a translation of the original German-language annual report.

About This Publication

Published by Sartorius AG Corporate Communications 37070 Goettingen, Germany

Editorial Deadline February 18, 2019

Published on February 19, 2019

Financial Reporting System firesys firesys GmbH Frankfurt | Main, Germany

Photography Peter Ginter

Lohmar, Germany

Frank Stefan Kimmel Goettingen

Sartorius AG Otto-Brenner-Strasse 2037079 Goettingen, Germany

Phone: +49.551.308.0Fax: +49.551.308.3289

info@sartorius.comwww.sartorius.com

©Sar

tori

us A

G |

Pri

nted

in G

erm

any

turning science into solutions